Stay updated on Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial

Sign up to get notified when there's something new on the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page

  1. Check
    5 days ago
    No Change Detected
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    Change Detected
    Summary
    The page footer shows an updated ClinicalTrials.gov revision identifier from v3.5.2 to v3.5.3, indicating a system/version update without changing the study details.
    Difference
    0.0%
    Check dated 2026-04-26T15:48:23.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T14:31:00.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Revision label updated to v3.5.0 (from v3.4.3).
    Difference
    0.0%
    Check dated 2026-03-22T03:56:48.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3. The previous label v3.4.2 has been removed.
    Difference
    0.0%
    Check dated 2026-03-07T17:21:33.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.2, replacing Revision: v3.4.1. This appears to be a minor maintenance update and does not change study information; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T04:43:52.000Z thumbnail image
  8. Check
    98 days ago
    Change Detected
    Summary
    Site revision updated from v3.4.0 to v3.4.1. This change does not affect any study details, eligibility criteria, results, or timeframes.
    Difference
    0.0%
    Check dated 2026-02-07T03:50:57.000Z thumbnail image

Stay in the know with updates to Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nanoliposomal Irinotecan vs Nab-paclitaxel/Gemcitabine Clinical Trial page.